Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn

被引:0
作者
Reefhuis, J [1 ]
Rasmussen, SA
Friedman, JM
机构
[1] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA
[2] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2188 / 2189
页数:2
相关论文
共 5 条
[1]   Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn [J].
Chambers, CD ;
Hernandez-Diaz, S ;
Van Marter, LJ ;
Werler, MM ;
Louik, C ;
Jones, KL ;
Mitchell, AA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :579-587
[2]  
*FOOD DRUG ADM CTR, 2005, FDA PUBL HLTH ADV PA, P12004
[3]   Neonatal abstinence syndrome after in utero exposure to selective serotonin Reuptake inhibitors in term infants [J].
Levison-Castiel, R ;
Merlob, P ;
Linder, N ;
Sirota, L ;
Klinger, G .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2006, 160 (02) :173-176
[4]   Depressing observations on the use of selective serotonin-reuptake inhibitors during pregnancy [J].
Mills, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :636-638
[5]   The National Birth Defects Prevention Study [J].
Yoon, PW ;
Rasmussen, SA ;
Lynberg, MC ;
Moore, CA ;
Anderka, M ;
Carmichael, SL ;
Costa, P ;
Druschel, C ;
Hobbs, CA ;
Romitti, PA ;
Langlois, PH ;
Edmonds, LD .
PUBLIC HEALTH REPORTS, 2001, 116 :32-40